JP2009126830A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009126830A5 JP2009126830A5 JP2007303850A JP2007303850A JP2009126830A5 JP 2009126830 A5 JP2009126830 A5 JP 2009126830A5 JP 2007303850 A JP2007303850 A JP 2007303850A JP 2007303850 A JP2007303850 A JP 2007303850A JP 2009126830 A5 JP2009126830 A5 JP 2009126830A5
- Authority
- JP
- Japan
- Prior art keywords
- valine
- leucine
- active ingredients
- isoleucine
- antidepressant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 4
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 4
- 229960000310 isoleucine Drugs 0.000 claims description 4
- 239000004474 valine Substances 0.000 claims description 4
- 230000001430 anti-depressive effect Effects 0.000 claims description 2
- 230000003262 anti-osteoporosis Effects 0.000 claims description 2
- 230000002180 anti-stress Effects 0.000 claims description 2
- 239000000935 antidepressant agent Substances 0.000 claims description 2
- 229940005513 antidepressants Drugs 0.000 claims 1
Description
請求項１に記載の発明は、イソロイシン、ロイシンおよびバリンを有効成分とする、抗鬱・抗ストレス剤である。
請求項２に記載の発明は、イソロイシン、ロイシンおよびバリンを有効成分とする、抗骨粗鬆症剤である。
The invention according to claim 1 is an anti-depressant / anti-stress agent comprising isoleucine, leucine and valine as active ingredients.
The invention according to claim 2 is an anti-osteoporosis agent comprising isoleucine, leucine and valine as active ingredients.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007303850A JP2009126830A (en) | 2007-11-26 | 2007-11-26 | Therapeutic agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007303850A JP2009126830A (en) | 2007-11-26 | 2007-11-26 | Therapeutic agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009126830A JP2009126830A (en) | 2009-06-11 |
| JP2009126830A5 true JP2009126830A5 (en) | 2011-01-20 |
Family
ID=40818108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007303850A Pending JP2009126830A (en) | 2007-11-26 | 2007-11-26 | Therapeutic agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2009126830A (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6119969B2 (en) * | 2013-01-25 | 2017-04-26 | 味の素株式会社 | Amino acid-containing composition for lowering blood pressure |
| WO2018047980A1 (en) | 2016-09-09 | 2018-03-15 | 味の素株式会社 | Prevention or remediation composition for dementia or depression |
| CN108042634A (en) * | 2018-01-24 | 2018-05-18 | 江苏神华药业有限公司 | A kind of composition with effects of dispelling effects of alcohol and protecting liver and preparation method thereof |
-
2007
- 2007-11-26 JP JP2007303850A patent/JP2009126830A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011506530A5 (en) | ||
| CL2007003879A1 (en) | COMPOUNDS DERIVED FROM ARIL-CARBOXAMIDA; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS ALZHEIMER, EPILEPSY AND PARKINSON. | |
| BRPI0909030A2 (en) | modified release pharmaceutical compositions comprising mycophenolate and processes therefor. | |
| DK2464337T4 (en) | Tablet formulation of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide for use in the treatment of cystic fibrosis | |
| JP2011508579A5 (en) | ||
| BRPI0806531A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION, THERAPEUTIC AGENT, AND USE OF THE COMPOUND. | |
| CL2007003356A1 (en) | COMPOUNDS DERIVED FROM BENZOPIRAZOLES; PROCESS FOR THE PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS AND ANOTHER ACTIVE AGENT; AND ITS USE FOR THE TREATMENT OF ASTHMA, INFLAMMATION, AMONG OTHER DISEASES. | |
| CL2007001917A1 (en) | COMPOUNDS DERIVED FROM SIPROCICLIC AZAINDOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF PAIN, CONDITIONS OF PANIC, DEPRESSION, EVIL OF ALZHEIMER, MIGRANA, AMONG OTHERS. | |
| WO2009004593A3 (en) | Processes for the preparation of epinephrine | |
| IL191758A0 (en) | Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof | |
| WO2009125409A3 (en) | Fatty acid amides and uses thereof | |
| JP2013513660A5 (en) | ||
| JP2009126830A5 (en) | ||
| JP2009504909A5 (en) | ||
| JP2008542528A5 (en) | ||
| JP2009001575A5 (en) | ||
| JP2009532412A5 (en) | ||
| JP2009292763A5 (en) | ||
| JP2009120544A5 (en) | ||
| JP2011008097A5 (en) | ||
| WO2010129788A3 (en) | Uses of cationic hydroxythylcellulose in oral ingestion forms, and prevention and treatment of metabolic disorders | |
| JP2009509934A5 (en) | ||
| UA110091C2 (en) | CHRONOTHERAPY PHARMACEUTICAL COMPOSITION | |
| WO2011058572A3 (en) | Solid dapoxetine | |
| RU2007132381A (en) | HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTIVITY AGENT |